A consortium consisting of Sunstone Capital, CDC Innovation Funds, IDInvest Partners, and Life Science Partners, among others, have listed biopharmaceutical company Zealand Pharma A/S, raising net proceeds of DKK 320.6m for the company.
This article is only available to subscribers to unquote.com. Subscribers just need to log in below for immediate access. Not a subscriber? Sign up now for immediate free trial access
Sign up
Free trial
Try unquote.com free for 2 weeks. A trial will give you access to the entire site.